Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells
AA Sprouse, BS Herbert - Anticancer research, 2014 - ar.iiarjournals.org
Background: Resveratrol (RES) inhibits cell growth, induces apoptosis and augments
chemotherapeutics in multiple cancer types, although its effects on drug-resistant cancer …
chemotherapeutics in multiple cancer types, although its effects on drug-resistant cancer …
Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo
M Fukui, N Yamabe, BT Zhu - European journal of cancer, 2010 - Elsevier
It was reported recently that resveratrol could sensitise a number of cancer cell lines to the
anticancer actions of several other cancer drugs, including paclitaxel. In the present study …
anticancer actions of several other cancer drugs, including paclitaxel. In the present study …
[HTML][HTML] Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
F Huang, XN Wu, JIE Chen… - Experimental and …, 2014 - spandidos-publications.com
Although its mechanisms remain unidentified, resveratrol (trans‑3, 4', 5‑trihydroxystilbene;
RES), which is an active, low molecular-weight compound, possesses a unique antitumor …
RES), which is an active, low molecular-weight compound, possesses a unique antitumor …
[HTML][HTML] Molecular basis of resveratrol-induced resensitization of acquired drug-resistant cancer cells
CY Choi, SC Lim, TB Lee, SI Han - Nutrients, 2022 - mdpi.com
Multidrug resistance (MDR) to anticancer drugs remains a serious obstacle to the success of
cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts …
cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts …
Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
AM Al‐Abd, AM Mahmoud, GA El‐Sherbiny… - Cell …, 2011 - Wiley Online Library
Objectives: Resveratrol, with its robust antioxidant activity, has frequently been suggested as
potentially having activity in cancer prevention and some recent reports have indicated that it …
potentially having activity in cancer prevention and some recent reports have indicated that it …
[HTML][HTML] Resveratrol decreases Rad51 expression and sensitizes cisplatin‑resistant MCF‑7 breast cancer cells
I Leon‑Galicia, J Diaz‑Chavez… - Oncology …, 2018 - spandidos-publications.com
Resveratrol (RES), a polyphenol compound with anti‑proliferative properties, has been
previously evaluated for its beneficial effects against a variety of tumour cells. The current …
previously evaluated for its beneficial effects against a variety of tumour cells. The current …
Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin
TH Kim, YJ Shin, AJ Won, BM Lee, WS Choi… - … et Biophysica Acta (BBA …, 2014 - Elsevier
Background Multidrug resistance is a major problem in the treatment of breast cancer, and a
number of studies have attempted to find an efficient strategy with which to overcome it. In …
number of studies have attempted to find an efficient strategy with which to overcome it. In …
[HTML][HTML] Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2 …
As breast cancer cells often develop chemoresistance, better therapeutic options are in
search to circumvent it. Here we demonstrate that human epidermal growth factor receptor-2 …
search to circumvent it. Here we demonstrate that human epidermal growth factor receptor-2 …
Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
X Jin, Y Wei, Y Liu, X Lu, F Ding, J Wang… - Cancer …, 2019 - Wiley Online Library
Breast cancer is one of the leading fatal diseases for women worldwide who cannot have
surgery typically have to rely on systemic chemotherapy to extend their survival. Doxorubicin …
surgery typically have to rely on systemic chemotherapy to extend their survival. Doxorubicin …
Reversal effect of resveratrol on multidrug resistance in KBv200 cell line
F Quan, C Pan, Q Ma, S Zhang, L Yan - Biomedicine & pharmacotherapy, 2008 - Elsevier
A multidrug-resistant clone of human oral epidermoid carcinoma KB cells was isolated by
stepwise selection on exposure to increasing doses of vincristine. The final clone, KBv200 …
stepwise selection on exposure to increasing doses of vincristine. The final clone, KBv200 …